Trial · NCT02048371
Adverse events1,008
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,008
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Cohort A: Liposarcoma | 0 | 39 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Cohort A: Liposarcoma, Placebo | 0 | 9 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Cohort B: Osteosarcoma | 0 | 33 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Cohort B: Osteosarcoma, Placebo | 1 | 9 | 1 |
| other | Anemia | Blood and lymphatic system disorders | Cohort C: Ewing Sarcoma | 0 | 30 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Cohort D: Rhabdomyosarcoma | 0 | 6 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Cohort D: Pediatric | 0 | 4 | 0 |
| other | Anemia | Blood and lymphatic system disorders | Cohort E: Mesenchymal Chondrosarcoma | 0 | 1 | 0 |
| other | Hypertension | Blood and lymphatic system disorders | Cohort A: Liposarcoma | 0 | 39 | 0 |
| other | Hypertension | Blood and lymphatic system disorders | Cohort A: Liposarcoma, Placebo | 0 | 9 | 0 |
| other | Hypertension | Blood and lymphatic system disorders | Cohort B: Osteosarcoma | 10 | 33 | 19 |
| other | Hypertension | Blood and lymphatic system disorders | Cohort B: Osteosarcoma, Placebo | 1 | 9 | 12 |
| other | Hypertension | Blood and lymphatic system disorders | Cohort C: Ewing Sarcoma | 0 | 30 | 0 |
| other | Hypertension | Blood and lymphatic system disorders | Cohort D: Rhabdomyosarcoma | 0 | 6 | 0 |
| other | Hypertension | Blood and lymphatic system disorders | Cohort D: Pediatric | 0 | 4 | 0 |
| other | Hypertension | Blood and lymphatic system disorders | Cohort E: Mesenchymal Chondrosarcoma | 0 | 1 | 0 |
| other | Alkaline Phosphatase Elevated | Endocrine disorders | Cohort A: Liposarcoma | 0 | 39 | 0 |
| other | Alkaline Phosphatase Elevated | Endocrine disorders | Cohort A: Liposarcoma, Placebo | 0 | 9 | 0 |
| other | Alkaline Phosphatase Elevated | Endocrine disorders | Cohort B: Osteosarcoma | 2 | 33 | 3 |
| other | Alkaline Phosphatase Elevated | Endocrine disorders | Cohort B: Osteosarcoma, Placebo | 2 | 9 | 4 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02048371/events